USD 0.01
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2022 | 18.95 Thousand CAD | -66.31% |
2021 | 56.27 Thousand CAD | 250.79% |
2020 | 16.04 Thousand CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
2008 | - CAD | 0.0% |
2007 | - CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2023 Q2 | - CAD | 0.0% |
2023 Q1 | - CAD | -100.0% |
2023 Q3 | - CAD | 0.0% |
2022 Q2 | 3403.00 CAD | -51.32% |
2022 Q1 | 6991.00 CAD | -40.53% |
2022 FY | 18.95 Thousand CAD | -66.31% |
2022 Q4 | 1228.00 CAD | -83.26% |
2022 Q3 | 7336.00 CAD | 115.57% |
2021 Q3 | 25.74 Thousand CAD | 97.33% |
2021 Q4 | 11.75 Thousand CAD | -54.34% |
2021 FY | 56.27 Thousand CAD | 250.79% |
2021 Q1 | 5719.00 CAD | -64.35% |
2021 Q2 | 13.04 Thousand CAD | 128.15% |
2020 FY | 16.04 Thousand CAD | 0.0% |
2020 Q1 | - CAD | 100.0% |
2020 Q2 | - CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 Q4 | 16.04 Thousand CAD | 0.0% |
2019 Q2 | 100.63 Thousand CAD | -76.53% |
2019 Q1 | 428.85 Thousand CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2019 Q3 | 29.45 Thousand CAD | -70.73% |
2019 Q4 | -558.94 Thousand CAD | -1997.36% |
2018 Q3 | 1.33 Million CAD | 37.36% |
2018 FY | - CAD | 0.0% |
2018 Q1 | 1.22 Million CAD | 0.0% |
2018 Q4 | - CAD | -100.0% |
2018 Q2 | 968.43 Thousand CAD | -21.22% |
2017 Q4 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 Q2 | - CAD | 0.0% |
2010 Q1 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2009 Q1 | - CAD | 0.0% |
2009 Q4 | - CAD | 0.0% |
2009 Q3 | - CAD | 0.0% |
2009 Q2 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
2008 Q3 | - CAD | 0.0% |
2008 Q1 | - CAD | 0.0% |
2008 FY | - CAD | 0.0% |
2008 Q4 | - CAD | 0.0% |
2008 Q2 | - CAD | 0.0% |
2007 Q3 | - CAD | 0.0% |
2007 FY | - CAD | 0.0% |
2007 Q4 | - CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
China Medicine Corporation | 64.75 Million USD | 99.971% |
DH Enchantment Inc. | 686.00 USD | -2663.557% |
Exlites Holdings International, Inc. | 18.74 Thousand USD | -1.163% |
Itonis, Inc. | 1801.00 USD | -952.637% |
One Step Vending Corp. | - USD | -Infinity% |
MediPal Holdings Corporation | 23.51 Billion USD | 100.0% |
PD-Rx Pharmaceuticals, Inc. | 21.27 Million USD | 99.911% |
Pharmagen, Inc. | 4813.05 USD | -293.887% |
Suzuken Co., Ltd. | 15.76 Billion USD | 100.0% |